Drawing for OPTIPEAK

USPTO serial 88149155

OPTIPEAK

Reviewed by CopyMark Law Group

Reg. 5768032Status 702Registered
Filing date
Status date
Registration date
Jun 4, 2019
Examiner
MCCARTHY, BRIDGET ANN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with OPTIPEAK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Crissa A. Cook

Crissa A. Cook HOVEY WILLIAMS LLP10801 Mastin Blvd., Suite 1000OVERLAND PARK, KS 66210-1697United States

Goods and services

ClassDescriptionStatusFirst use
001Cell culture media for laboratory use; cell culture media for use in scientific research; non-animal derived cell culture media and media supplements for growing cells for scientific and research use; non-animal derived biological preparations for use in cell cultures other than for medical or veterinary use; cell culture media for manufacturing of gene therapies, vaccines, cell therapies, and regenerative medicinesACTIVESep 5, 2017
005Non-animal derived cell culture media for cultivating human, animal, plant or microorganism cells; cell culture reagents for medical or clinical medical use; cell culture reagents for medical diagnostic useACTIVESep 5, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 8, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 8, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 10, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jun 4, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 13, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 4, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 14, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 11, 2019ALIEASSIGNED TO LIE—
Jan 26, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2018GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 19, 2018GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 19, 2018CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 13, 2018DOCKASSIGNED TO EXAMINER—
Oct 20, 2018MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 19, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 13, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance